By Diana Novak Jones Dec 12 (Reuters) - A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ovarian cancer. The jury in Los Ang ...

State had accused company of under-reimbursing independent pharmacies and inflating drug prices.

NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a clinical-stage biopharmaceutical company ...

The Delhi High Court ruled against Novo Nordisk's request to block Dr Reddy's production of semaglutide for export. The case ...

The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...

A California jury has ordered Johnson & Johnson to pay $40 million in damages to two women who claimed the company’s baby ...

The ED conducted early morning raids on Friday at 25 locations across Lucknow, Ranchi, Ahmedabad and several other cities.

The patchwork rollout of a gene therapy exposes weaknesses in the pricing and regulatory frameworks that determine who ...

The Delhi High Court has overturned a Trade Marks Registry order that had rejected an objection filed by German fashion label Street One against the registration of the mark “Street 9.” The ...

They might be on to something.

How BioRender and CEO Shiz Aoki are turning a standard visual language for biology into must-have AI infrastructure, from ...

Gujarat High Court held that reopening assessment beyond four years is invalid when all material facts were disclosed. Depreciation claims on Slump Sale assets remain ...